Skip to main content Skip to navigation
We care about your privacy. Read about your rights and how we protect your data. Get Details

Education & Training

  • Fellowship Program, Pediatric Neuro-Oncology, 2010
    Duke University Medical Center
  • Fellowship Program, Pediatric Hematology/Oncology, 2008
    Duke University Medical Center
  • Residency Program, Pediatrics, 2005
    Hasbro Children's Hospital
  • Internship Program, Pediatrics, 2003
    Hasbro Children's Hospital
  • MD, 2002
    Duke University School of Medicine
  • BA, 1997
    Rice University

Board Certifications

  • American Board of Pediatrics/Hematology-Oncology

National Provider ID: 1356532592


Eugene Hwang, M.D., is part of Children's National Health System neuro-oncology team and focuses on treating children with brain tumors. Dr. Hwang’s undergraduate work was in cellular and molecular biology at Rice University in Houston, Texas. After completing medical school at Duke University, Dr. Hwang completed residency at Brown University Medical Center before returning to Duke University Medical Center for both his pediatric hematology-oncology and neuro-oncology fellowships. While at Duke, he conducted research focused on finding new treatments for childhood medulloblastoma. He is passionate about improving the care of children with brain tumors, and is currently involved in innovative clinical research to quickly find new and effective treatments. Dr. Hwang is an avid outdoorsman, enjoying fishing, camping, and other similar activities, although he can also be found cooking in his spare time. He is a fan of college sports in general, and roots for either his alma mater (the Rice University Owls) or the Texas A&M Aggies. He has two young daughters and is married to Dr. Kristina Hardy, who is a pediatric neuro-psychologist at Children's National. 

Hwang E, Gururangan S, Herndon JE, Fuchs H, George T, Coleman RE. Fluorodeoxyglucose-positron emission tomography in patients with medulloblastoma. Neurosurgery. 2004;55(6):1280-1289. doi:10.1227/01.neu.0000143027.41632.2b.

Hwang EI, Jakacki RI, Fisher MJ, et al. Long-term efficacy and toxicity of bevacizumab-based therapy in children with recurrent low-grade gliomas. Pediatric Blood & Cancer. 2012;60(5):776-782. doi:10.1002/pbc.24297.

Hwang EI, Emmenegger BA, et al. Distinct roles for fibroblast growth factor signaling in cerebellar development and medulloblastoma. Oncogene. 2012;32(35):4181-4188. doi:10.1038/onc.2012.440.

Hwang EI, Spence T, Sin-Chan P, et al. CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity. Acta Neuropathologica. 2014;128(2):291-303. doi:10.1007/s00401-014-1291-1.

Hwang EI, Bornhorst M. Experimental therapeutic trial design for pediatric brain tumors. Journal of Child Neurology. 2016;31(12):1421-1432. doi:10.1177/0883073815604221.

Hwang EI, Ramaswamy V, Hielscher T, et al. Therapeutic impact of cytoreductive surgery and irradiation of posterior fossa ependymoma in the molecular era: a retrospective multicohort analysis. Journal of Clinical Oncology. 2016;34(21):2468-2477. doi:10.1200/JCO.2015.65.7825.

Hwang EI, Nazarian J, Mason GE, et al. Histological and molecular analysis of a progressive diffuse intrinsic pontine glioma and synchronous metastatic lesions: a case report. Oncotarget. 2016;7(27):42837-42842. doi:10.18632/oncotarget.10034.

Hwang EI, Pajtler KW, Mack SC, et al. The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants. Acta Neuropathologica. 2017;133(1):5-12. doi:10.1007/s00401-016-1643-0.